OPCH vs TGTX: fair value comparison
Option Care Health, Inc. and TG Therapeutics, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, TGTX currently sits closer to the top of our discount ranking. OPCH carries the stronger quality grade.
| OPCH | TGTX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.70 | $46.17 |
| 12-month range | $20.03–$34.61 | $29.18–$53.52 |
| Sector rank | #8 of 113 Healthcare | #2 of 113 Healthcare |
| Quality grade | C | D |
| Leverage | Low | — |
| Margin trend | Contracting | Contracting |
| Revenue growth | Strong | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | Fairly Valued | — |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: OPCH fair value analysis · TGTX fair value analysis